Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness app may soothe heartburn and anxiety in GERD patients

NCT ID NCT07667894

Symptom relief Sponsor: Xinghua Liu Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 11, 2026 · Updated 3 times

Summary

This study tests whether an 8-week online mindfulness program can reduce emotional distress and reflux symptoms in 500 adults with gastroesophageal reflux disease (GERD). Participants are randomly assigned to either the mindfulness program or usual care. The goal is to see if learning to manage emotions can improve quality of life and reduce the burden of GERD.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
online mindfulness-based emotion intervention (MIED)
What this could lead to
If it works, this could offer a drug-free way to reduce stress and reflux symptoms for people with GERD.
What could go wrong
This is an early-stage trial with no prior results. The intervention is behavioral, so benefits may be modest and not replace standard medical care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Participants must meet all of the following criteria: 1. Aged 18 to 65 years. 2. GERD-Q score of 8 or higher. 3. Willingness to maintain a relatively stable usual treatment regimen during the study unless medically indicated changes are required. 4. Ability to use a smartphone, computer, or tablet to participate in the online program and complete online questionnaires. 5. Willingness to comply with course training and follow-up assessments. 6. Ability to understand the study and provide written or electronic informed consent. Exclusion Criteria Participants meeting any of the following criteria will be excluded: 1. Alarm symptoms or high suspicion of serious organic disease, including but not limited to progressive dysphagia, hematemesis, melena, unexplained weight loss, anemia, recurrent vomiting, or persistent chest pain without exclusion of cardiovascular risk. 2. Current or previous severe esophageal organic disease or gastrointestinal malignancy. 3. History of anti-reflux surgery, partial gastrectomy, or other upper gastrointestinal surgery that may substantially affect reflux symptom assessment. 4. GERD-Q score greater than 15, or symptoms judged by the study physician to be extremely severe and requiring priority medical evaluation or intensified treatment. 5. Current uncontrolled severe mental disorder, such as schizophrenia, manic episode of bipolar disorder, acute severe depressive episode, or severe substance use disorder. 6. Current suicide risk, operationalized as a score greater than 1 on item 9 of the PHQ-9. 7. Previous systematic participation in MIED, mindfulness-based stress reduction, mindfulness-based cognitive therapy, or another structured mindfulness program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emotional distress are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emotional distress Gastroesophageal reflux disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    15 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Affiliated Houspital of Chifeng University

    RECRUITING

    Chifeng, Inner Mongolia, 024000, China

  • Baiyin Central Hospital

    RECRUITING

    Baiyin, Gansu, 730913, China

  • Being Haidian Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100080, China

  • Center Hospital Qinghe County

    NOT_YET_RECRUITING

    Xingtai, Hebei, 054899, China

  • Changzhi People'S Hospital

    NOT_YET_RECRUITING

    Changzhi, Shanxi, 046000, China

  • PLA Rocket Force Characteristic Medical Center

    RECRUITING

    Beijing, Beijing Municipality, 100088, China

  • Peking University

    RECRUITING

    Beijing, Beijing Municipality, 100871, China

  • Peking University Shenzhen Hospital

    RECRUITING

    Shenzhen, Guangdong, 518036, China

  • Shandong Second Provincial General Hospital

    RECRUITING

    Jinan, Shandong, 250022, China

  • Shanghai sixth people's hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200233, China

  • The First Affiliated Hospital of Nanjing Medical University

    RECRUITING

    Nanjing, Jiangsu, 210029, China

  • Xilingol League Mongolian Medicine Hospital

    RECRUITING

    Hohhot, Inner Mongolia, 026000, China

  • Xinle City Hospital

    RECRUITING

    Xinle, Hebei, 050700, China

  • the Second People's Hospital of Liaocheng

    RECRUITING

    Liaocheng, Shandong, 252600, China

  • the first affiliated hospital of GuiZhou medical university

    NOT_YET_RECRUITING

    Guiyang, Guizhou, 550004, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.